51 related articles for article (PubMed ID: 26369723)
1. A knot polymer mediated non-viral gene transfection for skin cells.
Cutlar L; Gao Y; Aied A; Greiser U; Murauer EM; Zhou D; Wang W
Biomater Sci; 2016 Jan; 4(1):92-5. PubMed ID: 26369723
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell (iPSC) line MLi005-A derived from a patient with dominant dystrophic epidermolysis bullosa (DDEB).
Ropret S; Khurana P; Fabčič T; Cvetkovska J; Trobec A; Jokhadar ŠZ; Ilic D; McGrath JA; Guttmann-Gruber C; Liovic M
Stem Cell Res; 2024 Mar; 75():103306. PubMed ID: 38271763
[TBL] [Abstract][Full Text] [Related]
3. Collagen VII maintains proteostasis in dermal fibroblasts by scaffolding TANGO1 cargo.
Cao Q; Tartaglia G; Alexander M; Park PH; Poojan S; Farshchian M; Fuentes I; Chen M; McGrath JA; Palisson F; Salas-Alanis J; South AP
Matrix Biol; 2022 Aug; 111():226-244. PubMed ID: 35779741
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9-based non-viral gene editing therapy for topical treatment of recessive dystrophic epidermolysis bullosa.
Wang X; Wang X; Li Y; A S; Qiu B; Bushmalyova A; He Z; Wang W; Lara-Sáez I
Mol Ther Methods Clin Dev; 2023 Dec; 31():101134. PubMed ID: 38027067
[TBL] [Abstract][Full Text] [Related]
5. Superior COL7A1 and TGM1 gene expression in difficult-to-transfect skin cell mediated by highly branched poly(β-amino esters) through stepwise fractionation.
Pan C; Wang C; Zhao Y; Bo T; Han L; Yao D; Wang Y; Wang X; Shi L; Zhao A; Cao Q; Chen F; He W; Ye Y; Zhang S; Li M
J Control Release; 2024 Jun; 370():82-94. PubMed ID: 38643938
[TBL] [Abstract][Full Text] [Related]
6. Cyclization-enhanced poly(β-amino ester)s vectors for efficient CRISPR gene editing therapy.
Wang X; Li Y; A S; Lyu J; Wang X; He Z; Lara-Sáez I; Li M; Wang W
J Control Release; 2024 Apr; 368():444-452. PubMed ID: 38401849
[TBL] [Abstract][Full Text] [Related]
7. Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa.
Watt SA; Dayal JH; Wright S; Riddle M; Pourreyron C; McMillan JR; Kimble RM; Prisco M; Gartner U; Warbrick E; McLean WH; Leigh IM; McGrath JA; Salas-Alanis JC; Tolar J; South AP
PLoS One; 2015; 10(9):e0137639. PubMed ID: 26380979
[TBL] [Abstract][Full Text] [Related]
8. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells.
Jacków J; Guo Z; Hansen C; Abaci HE; Doucet YS; Shin JU; Hayashi R; DeLorenzo D; Kabata Y; Shinkuma S; Salas-Alanis JC; Christiano AM
Proc Natl Acad Sci U S A; 2019 Dec; 116(52):26846-26852. PubMed ID: 31818947
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.
Rashidghamat E; Kadiyirire T; Ayis S; Petrof G; Liu L; Pullabhatla V; Ainali C; Guy A; Aristodemou S; McMillan JR; Ozoemena L; Mee J; Pramanik R; Saxena A; Nuamah R; de Rinaldis E; Serrano S; Maurin C; Martinez-Queipo M; Lwin SM; Ilic D; Martinez A; Dazzi F; Slaper-Cortenbach I; Westinga K; Zeddies S; van den Broek M; Onoufriadis A; Mellerio JE; McGrath JA
J Am Acad Dermatol; 2020 Aug; 83(2):447-454. PubMed ID: 31786163
[TBL] [Abstract][Full Text] [Related]
11. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy for Epidermolysis Bullosa.
Marinkovich MP; Tang JY
J Invest Dermatol; 2019 Jun; 139(6):1221-1226. PubMed ID: 31068252
[TBL] [Abstract][Full Text] [Related]
13. Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells.
Mencía Á; Chamorro C; Bonafont J; Duarte B; Holguin A; Illera N; Llames SG; Escámez MJ; Hausser I; Del Río M; Larcher F; Murillas R
Mol Ther Nucleic Acids; 2018 Jun; 11():68-78. PubMed ID: 29858091
[TBL] [Abstract][Full Text] [Related]
14. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
[TBL] [Abstract][Full Text] [Related]
15. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
[TBL] [Abstract][Full Text] [Related]
16. Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes.
Chamorro C; Mencía A; Almarza D; Duarte B; Büning H; Sallach J; Hausser I; Del Río M; Larcher F; Murillas R
Mol Ther Nucleic Acids; 2016 Apr; 5(4):e307. PubMed ID: 27045209
[TBL] [Abstract][Full Text] [Related]
17. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
[TBL] [Abstract][Full Text] [Related]
18. A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair.
Peking P; Koller U; Hainzl S; Kitzmueller S; Kocher T; Mayr E; Nyström A; Lener T; Reichelt J; Bauer JW; Murauer EM
Mol Ther Nucleic Acids; 2016 Mar; 5():e287. PubMed ID: 26928235
[TBL] [Abstract][Full Text] [Related]
19. Epidermolysis bullosa: Advances in research and treatment.
Prodinger C; Reichelt J; Bauer JW; Laimer M
Exp Dermatol; 2019 Oct; 28(10):1176-1189. PubMed ID: 31140655
[TBL] [Abstract][Full Text] [Related]
20. Design of Oligonucleotide Carriers: Importance of Polyamine Chain Length.
Annenkov VV; Krishnan UM; Pal'shin VA; Zelinskiy SN; Kandasamy G; Danilovtseva EN
Polymers (Basel); 2018 Nov; 10(12):. PubMed ID: 30961222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
